# Whitehead Institute for Biomedical Research

Whitehead Institute for Biomedical Research is an Endowment / Foundation based in Cambridge, United States.

## Overview

- **Organization type:** Endowment / Foundation
- **Headquarters:** Cambridge, United States
- **Region:** North America
- **Address:** Cambridge, MA, United States
- **Founded:** 1982
- **Assets under management:** 734 (Altss estimate)
- **Website:** wi.mit.edu
- **LinkedIn:** https://www.linkedin.com/company/whitehead-institute

## Regulatory record

- **Reports private funds:** No

## About

The Whitehead Institute was established in 1982 through a $135 million gift from industrialist Edwin C. Whitehead. David Baltimore served as its founding director. The institute functions as both a research center and a grant-making entity focused on health and education. Its endowment portfolio contains common stocks, mutual funds, global equities, hedge funds, and resource funds. Confirmed holdings include long equity positions in Alnylam Pharmaceuticals, Ironwood Pharmaceuticals, and Fate Therapeutics. Private investments cover CAMP4 Therapeutics, Dewpoint Therapeutics, Omega Therapeutics, Syros Pharmaceuticals, and Verastem Oncology. Activity centers on North America with primary operations in Cambridge, Massachusetts. The institute employs direct deal and philanthropic structures. It maintains membership in the Massachusetts Biotechnology Council and the Kendall Square Association. No dated operational events from the last 24 months appear in available records. The institute's architecture rests on its hybrid status as an independent research entity with a permanent MIT faculty tie. All Whitehead Members hold MIT appointments, creating a distinct governance and talent pipeline not replicated in standard endowments or foundations.

## Sectors

- Digital Health
- Biotech
- AI/ML

## People

- Ruth Lehmann — Director and President
- Edwin C. Whitehead — Founder

## Questions

### Who runs investment decisions at Whitehead Institute for Biomedical Research?

Ruth Lehmann serves as Director and President. Investment oversight occurs through the institute's board and staff with support from external advisors including State Street Bank as custodian.

### Does Whitehead Institute participate in fund commitments or only direct deals?

The institute makes direct investments in startups and holds public equity positions. It also maintains alternative investments including hedge funds and resource funds.

### What investment stages does Whitehead Institute typically target?

Activity includes seed-stage commitments alongside public market holdings. Private positions focus on early biotechnology companies.

### How is Whitehead Institute related to MIT?

The institute shares a teaching and research affiliation with MIT. All Whitehead Members hold faculty appointments at MIT.

## Related profiles

- [Jewish Federation of Metropolitan Detroit and United Jewish Foundation](https://altss.com/profile/jewish-federation-of-metropolitan-detroit-and-united-jewish-foundation-jfd-and-ujf)
- [Astellas Pharma Japan Pension Scheme](https://altss.com/profile/astellas-pharma-japan-pension-scheme)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/whitehead-institute-for-biomedical-research

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology